Abstract
Purpose
This study evaluated the significance of combining tumor markers (TM) and systemic immune-inflammation index (SII) for postoperative complications and long-term outcomes in colorectal cancer (CRC) patients.
Methods
CRC patients (662) who underwent surgery between 2012 and 2014 were retrospectively enrolled into our study. Factors affecting postoperative complications were evaluated by logistic regression analysis. Prognostic factors were assessed using Kaplan-Meier and Cox proportional hazards models. Nomograms were constructed to predict the risk of postoperative complications and survival. A consistency index and a calibration curve were used to evaluate the predictive accuracy of nomograms.
Results
TM-SII score was established by combining TM and SII. Logistic regression analyses showed that TM-SII score was an important predictor of postoperative complications in CRC patients. Kaplan-Meier analyses showed that TM-SII score was favorable for prognostic risk stratification. In addition, multivariate analyses indicated that TM-SII score was an independent prognostic indicator for disease-free survival and overall survival. TM-SII based nomograms had a moderate prediction accuracy.
Conclusion
TM-SII score is a good prognostic indicator for CRC patients. It may be used as a useful risk stratification tool for advanced CRC patients. TM-SII-based nomograms could be used to identify CRC patients with poor outcomes.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132
Nakamura Y, Yoshino T (2018) Clinical utility of analyzing circulating tumor DNA in patients with metastatic colorectal cancer. Oncologist 23(11):1310–1318
Chen T, Yu L, Li B, Zhang F, Wang Y, Wang X, Liu S, Yang C, Qi H, Yu M (2017) Elevated preoperative carcinoembryonic antigen and vascular endothelial growth factor predict shorter survival in patients with sigmoid colon carcinoma. Clin Lab 63(3):445
Peng Y, Zhai Z, Li Z, Wang L, Gu J (2015) Role of blood tumor markers in predicting metastasis and local recurrence after curative resection of colon cancer. Int J Clin Exp Med 8(1):982
Shinkins B, Nicholson BD, Primrose J, Perera R, James T, Pugh S, Mant D (2017) The diagnostic accuracy of a single CEA blood test in detecting colorectal cancer recurrence: results from the FACS trial. PLoS One 12(3)
Huang S-C, Huang S-F, Chen Y-T, Chang Y, Chiu Y-T, Chang I-C, Wu H-DI, Chen J-S (2017) Overexpression of MutL homolog 1 and MutS homolog 2 proteins have reversed prognostic implications for stage I–II colon cancer patients. Biom J 40(1):39–48
Dev R, Wong A, Hui D, Bruera E (2017) The evolving approach to management of cancer cachexia. Oncology 31(1)
Jagadesham V, Lagarde S, Immanuel A, Griffin S (2017) Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. Br J Surg 104(4):401–407
Dolan RD, McSorley ST, Park JH, Watt DG, Roxburgh CS, Horgan PG, McMillan DC (2018) The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer 119(1):40–51
Chen J-H, Zhai E-T, Yuan Y-J, Wu K-M, Xu J-B, Peng J-J, Chen C-Q, He Y-L, Cai S-R (2017) Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol 23(34):6261
Wang L, Wang C, Wang J, Huang X, Cheng Y (2017) A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 143(10):2077–2086
Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259. https://doi.org/10.1158/1078-0432.ccr-04-0713
Maas M, Rutten IJ, Nelemans PJ, Lambregts DM, Cappendijk VC, Beets GL, Beets-Tan RG (2011) What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis. Eur J Nucl Med Mol Imaging 38(8):1560–1571
Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, Sakuma S (1992) Recurrent rectal cancer and scar: differentiation with PET and MR imaging. Radiology 182(2):549–552
Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351(26):2704–2714. https://doi.org/10.1056/NEJMoa033403
Sibio S, Di Giorgio A, D’Ugo S, Palmieri G, Cinelli L, Formica V, Sensi B, Bagaglini G, Di Carlo S, Bellato V, Sica GS (2019) Histotype influences emergency presentation and prognosis in colon cancer surgery. Langenbeck's Arch Surg 404(7):841–851. https://doi.org/10.1007/s00423-019-01826-6
Tomita M, Ayabe T, Chosa E, Nakamura K (2015) Postoperative serum CEA level is a more significant prognostic factor than post/preoperative serum CEA ratio in non-small cell cancer patients. Asian Pac J Cancer Prev 16(17):7809–7812
Wang J, Lu C, Chu K, Ma C, Wu D, Tsai H, Yu F, Hsieh J (2007) Prognostic significance of pre-and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res 39(4):245–250
**e HL, Gong YZ, Kuang JA, Gao F, Tang SY, Gan JL (2019) The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels. Cancer Manag Res 11:7499–7511. https://doi.org/10.2147/cmar.s213580
Huang E-Y, Chang J-C, Chen H-H, Hsu C-Y, Hsu H-C, Wu K-L (2018) Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages. BMC Cancer 18(1):321
Qiao Y-F, Chen C-G, Yue J, Ma M-Q, Ma Z, Yu Z-T (2017) Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer. World J Gastroenterol 23(8):1424
Matsubara D, Arita T (2019) Preoperative inflammatory response as prognostic factor of patients with colon cancer. Langenbek's Arch Surg 404(6):731–741. https://doi.org/10.1007/s00423-019-01811-z
Tang S, **e H, Kuang J, Gao F (2020) The value of geriatric nutritional risk index in evaluating postoperative complication risk and long-term prognosis in elderly colorectal cancer patients. Cancer Manag Res 12:165–175. https://doi.org/10.2147/cmar.s234688
Hu B, Yang X-R, Xu Y, Sun Y-F, Sun C, Guo W, Zhang X, Wang W-M, Qiu S-J, Zhou J (2014) Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 20(23):6212–6222
Wang K, Diao F, Ye Z, Zhang X, Zhai E, Ren H, Li T, Wu H, He Y, Cai S (2017) Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Chin J Cancer 36(1):75
Moses K, Brandau S Human neutrophils: their role in cancer and relation to myeloid-derived suppressor cells. In: Seminars in immunology, 2016. vol 2. Elsevier, pp 187-196
Felix K, Gaida MM (2016) Neutrophil-derived proteases in the microenvironment of pancreatic cancer-active players in tumor progression. Int J Biol Sci 12(3):302–313
Orellana R, Kato S, Erices R, Bravo ML, Gonzalez P, Oliva B, Cubillos S, Valdivia A, Ibañez C, Brañes J (2015) Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer 15(1):290
Coupland LA, Parish CR Platelets, selectins, and the control of tumor metastasis. In: Seminars in oncology, 2014. vol 3. Elsevier, pp 422-434
Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9(1):69
Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69(13):5383–5391
**e Q-K, Chen P, Hu W-M, Sun P, He W-Z, Jiang C, Kong P-F, Liu S-S, Chen H-T, Yang Y-Z (2018) The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor. J Transl Med 16(1):1–8
Forget P, Dinant V, De Kock M (2015) Is the Neutrophil-to-Lymphocyte Ratio more correlated than C-reactive protein with postoperative complications after major abdominal surgery? PeerJ 3:e713
Manceau G, Voron T, Mege D, Bridoux V, Lakkis Z, Venara A, Beyer-Berjot L, Abdalla S, Sielezneff I, Lefèvre JH, Karoui M (2019) Prognostic factors and patterns of recurrence after emergency management for obstructing colon cancer: multivariate analysis from a series of 2120 patients. Langenbeck's Arch Surg 404(6):717–729. https://doi.org/10.1007/s00423-019-01819-5
Author information
Authors and Affiliations
Contributions
This study was designed by Jialiang Gan and Hailun **e. Hailun **e and Guanghui Yuan performed statistical analyses. The clinical information and materials were collected and kept by Guanghui Yuan, Shizhen Huang, Jiaan Kuang, Ling Yan, Guotian Ruan, and Shuangyi Tang. Hailun **e drafted the manuscript. Jialiang Gan edited and revised the manuscript. All authors approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
**e, H., Yuan, G., Huang, S. et al. The prognostic value of combined tumor markers and systemic immune-inflammation index in colorectal cancer patients. Langenbecks Arch Surg 405, 1119–1130 (2020). https://doi.org/10.1007/s00423-020-01963-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-020-01963-3